Literature DB >> 9192271

Metachromatic leucodystrophy in three families from Nova Scotia, Canada: a recurring mutation in the arylsulphatase A gene.

M B Coulter-Mackie1, L Gagnier, M J Beis, D A Applegarth, D E Cole, K Gordon, M D Ludman.   

Abstract

Metachromatic leucodystrophy (MLD) is a lysosomal storage disease resulting from a deficiency of arylsulphatase A. We have identified a child with infantile onset MLD who is homozygous for an A212V mutation, a mutation previously reported but not further characterised. We have introduced this mutation into an arylsulphatase A expression vector by site directed mutagenesis. Transient expression of this mutant plasmid in COS cells yields very low levels of arylsulphatase A activity consistent with the patient's phenotype. The arylsulphatase A pseudodeficiency also segregates in this family causing difficulty in interpreting enzyme levels in the absence of DNA data. Two other patients from the same province, also carrying the A212V allele, have juvenile and adult onset MLD and are heterozygous for P426L ("A" allele) and I179S alleles respectively, known late onset alleles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192271      PMCID: PMC1050974          DOI: 10.1136/jmg.34.6.493

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  A double mutation in exon 6 of the beta-hexosaminidase alpha subunit in a patient with the B1 variant of Tay-Sachs disease.

Authors:  P J Ainsworth; M B Coulter-Mackie
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

2.  The assay of arylsulphatases A and B in human urine.

Authors:  H BAUM; K S DODGSON; B SPENCER
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

3.  Site-directed mutagenesis of virtually any plasmid by eliminating a unique site.

Authors:  W P Deng; J A Nickoloff
Journal:  Anal Biochem       Date:  1992-01       Impact factor: 3.365

4.  Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone.

Authors:  A J Kirkilionis; D C Riddell; M W Spence; R G Fenwick
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

5.  Structure of the arylsulfatase A gene.

Authors:  J Kreysing; K von Figura; V Gieselmann
Journal:  Eur J Biochem       Date:  1990-08-17

6.  Evidence for a hybrid hexosaminidase isoenzyme in heterozygotes for Sandhoff disease.

Authors:  J A Lowden
Journal:  Am J Hum Genet       Date:  1979-05       Impact factor: 11.025

7.  Molecular basis of different forms of metachromatic leukodystrophy.

Authors:  A Polten; A L Fluharty; C B Fluharty; J Kappler; K von Figura; V Gieselmann
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

Review 8.  How sensitive is PCR-SSCP?

Authors:  K Hayashi; D W Yandell
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

9.  The differential diagnosis of adult onset metachromatic leukodystrophy and early onset familial Alzheimer disease in an Alzheimer clinic population.

Authors:  A D Sadovnick; H Tuokko; D A Applegarth; J R Toone; T Hadjistavropoulos; B L Beattie
Journal:  Can J Neurol Sci       Date:  1993-11       Impact factor: 2.104

10.  Missense mutations in the arylsulphatase A genes of metachromatic leukodystrophy patients.

Authors:  M L Barth; A Fensom; A Harris
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

View more
  2 in total

Review 1.  Metachromatic leukodystrophy: molecular genetics and an animal model.

Authors:  V Gieselmann; U Matzner; B Hess; R Lüllmann-Rauch; R Coenen; D Hartmann; R D'Hooge; P DeDeyn; G Nagels
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

2.  Metachromatic leukodystrophy: Characterization of two (p.Leu433Val, p.Gly449Arg) arylsulfatase A mutations.

Authors:  Yangyang Wang; Xiang Chen; Chan Liu; Shamin Wu; Qingfeng Xie; Quan Hu; Shan Chen; Yiwei Liu
Journal:  Exp Ther Med       Date:  2019-07-09       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.